Suppression of TLR2-induced il-12, reactive oxygen species, and inducible nitric oxide synthase expression by Mycobacterium tuberculosis antigens expressed inside macrophages during the course of infection

Journal of Immunology

Volumn 184, Issue 10, 2010, Pages 5444-5455

  Gupta, Deepti ^a   Sharma, Sachin ^a   Singhal, Jhalak ^a   Satsangi, Akash T ^a   Antony, Cecil ^a   Natarajan, Krishnamurthy ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; MYCOBACTERIUM ANTIGEN; REACTIVE OXYGEN METABOLITE; SUPPRESSOR OF CYTOKINE SIGNALING 1; TOLL LIKE RECEPTOR 2; BACTERIAL ANTIGEN; TLR2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; HUMAN; INFECTION RESISTANCE; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUBERCULOSIS; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; COMPARATIVE STUDY; DRUG ANTAGONISM; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LUNG TUBERCULOSIS; MACROPHAGE; METABOLISM; METHODOLOGY; MICROBIOLOGY; PATHOLOGY; PERITONEUM MACROPHAGE; PHYSIOLOGY; TIME; TUMOR CELL LINE;

ANIMALS; ANTIGENS, BACTERIAL; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-12; MACROPHAGES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE SYNTHASE TYPE II; REACTIVE OXYGEN SPECIES; TIME FACTORS; TOLL-LIKE RECEPTOR 2; TUBERCULOSIS, PULMONARY;

EID: 77954747891     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903283     Document Type: Article

References (44)

1. 2009. World Health Organization. World Health Organization Fact Sheet, Geneva, Switzerland. Available at: www.who.org.
2. Young, D. 2009. Animal models of tuberculosis. Eur. J. Immunol. 39: 2011-2014.
3. Ottenhoff, T. H. M. 2009. Overcoming the global crisis: "yes, we can", but also for TB...? Eur. J. Immunol. 39: 2014-2020.
4. Fine, P. E. M. 1995. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346: 1339-1345.
5. Hess, J. H., U. E. Schaible, B. Raupach, and S. H. E. Kaufmann. 2000. Exploiting the immune system: toward new vaccines against intracellular bacteria. Adv. Immunol. 75: 1-88.
6. Manabe, Y. C., and W. R. Bishai. 2000. Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting. Nat. Med. 6: 1327-1329.
7. Foote, S. 1999. Mediating immunity to mycobacteria. Nat. Genet. 21: 345-346.
8. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19: 93-129.
9. Steinman, R. M. 1999. Dendritic cells. In Fundamental Immunology. W. E. Paul, ed. Lippincott-Raven Publishers, Philadelphia, PA. p. 547-573.
10. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
11. Reis e Sousa, C. 2001. Dendritic cells as sensors of infection. Immunity 14: 495-498.
12. Tian, T., J. Woodworth, M. Sköld, and S. M. Behar. 2005. In vivo depletion of CD11c+ cells delays the CD4+ T cell response to Mycobacterium tuberculosis and exacerbates the outcome of infection. J. Immunol. 175: 3268-3272.
13. Pecora, N. D., S. A. Fulton, S. M. Reba, M. G. Drage, D. P. Simmons, N. J. Urankar-Nagy, W. H. Boom, and C. V. Harding. 2009. Mycobacterium bovis BCG decreases MHC-II expression in vivo on murine lung macrophages and dendritic cells during aerosol infection. Cell. Immunol. 254: 94-104.
14. Andersen, P. 1994. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 62: 2536-2544.
15. Roberts, A. D., M. G. Sonnenberg, D. J. Ordway, S. K. Furney, P. J. Brennan, J. T. Belisle, and I. M. Orme. 1995. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology 85: 502-508.
16. Roche, P. W., J. A. Triccas, D. T. Avery, T. Fifis, H. Billman-Jacobe, and W. J. Britton. 1994. Differential T cell responses to mycobacteria-secreted proteins distinguish vaccination with bacille Calmette-Guérin from infection with Mycobacterium tuberculosis. J. Infect. Dis. 170: 1326-1330.
17. Brandt, L., T. Oettinger, A. Holm, A. B. Andersen, and P. Andersen. 1996. Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. J. Immunol. 157: 3527-3533.
18. Elhay, M. J., T. Oettinger, and P. Andersen. 1998. Delayed-type hypersensitivity responses to ESAT-6 and MPT64 from Mycobacterium tuberculosis in the guinea pig. Infect. Immun. 66: 3454-3456.
19. Roche, P. W., N. Winter, J. A. Triccas, C. G. Feng, and W. J. Britton. 1996. Expression of Mycobacterium tuberculosis MPT64 in recombinant Myco. smegmatis: purification, immunogenicity and application to skin tests for tuberculosis. Clin. Exp. Immunol. 103: 226-232.
20. Tanghe, A., S. D'Souza, V. Rosseels, O. Denis, T. H. M. Ottenhoff, W. Dalemans, C. Wheeler, and K. Huygen. 2001. Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting. Infect. Immun. 69: 3041-3047.
21. Latchumanan, V. K., M. Y. Balkhi, A. Sinha, B. Singh, P. Sharma, and K. Natarajan. 2005. Regulation of immune responses to Mycobacterium tuberculosis secretory antigens by dendritic cells. Tuberculosis (Edinb.) 85: 377-383.
22. Latchumanan, V. K., B. Singh, P. Sharma, and K. Natarajan. 2002. Mycobacterium tuberculosis antigens induce the differentiation of dendritic cells from bone marrow. J. Immunol. 169: 6856-6864. (Pubitemid 36899271)
23. Natarajan, K., V. K. Latchumanan, B. Singh, S. Singh, and P. Sharma. 2003. Down-regulation of T helper 1 responses to mycobacterial antigens due to maturation of dendritic cells by 10-kDa mycobacterium tuberculosis secretory antigen. J. Infect. Dis. 187: 914-928.
24. Balkhi, M. Y., A. Sinha, and K. Natarajan. 2004. Dominance of CD86, transforming growth factor- beta 1 and interleukin-10 from Mycobacterium tuberculosis secretory antigen-activated dendritic cells regulate T helper 1 responses to mycobacterial antigens. J. Infect. Dis. 189: 1598-1609.
25. Sinha, A., A. Singh, V. Satchidanandam, and K. Natarajan. 2006. Impaired generation of reactive oxygen species during differentiation of dendritic cells (DCs) by Mycobacterium tuberculosis secretory antigen (MTSA) and subsequent activation of MTSA-DCs by mycobacteria results in increased intracellular survival. J. Immunol. 177: 468-478.
26. Rengarajan, J., B. R. Bloom, and E. J. Rubin. 2005. Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. Proc. Natl. Acad. Sci. U S A. 102: 8327-8332.
27. Singh, A., D. K. Crossman, D. Mai, L. Guidry, M. I. Voskuil, M. B. Renfrow, and A. J. C. Steyn. 2009. Mycobacterium tuberculosis WhiB3 maintains redox homeostasis by regulating virulence lipid anabolism to modulate macrophage response. PLoS Pathog. 5: e1000545.
28. Manganelli, R., R. Provvedi, S. Rodrigue, J. Beaucher, L. Gaudreau, I. Smith, and R. Proveddi. 2004. s factors and global gene regulation in Mycobacterium tuberculosis. J. Bacteriol. 186: 895-902.
29. Mack, U., G. B. Migliori, M. Sester, H. L. Rieder, S. Ehlers, D. Goletti, A. Bossink, K. Magdorf, C. Hölscher, B. Kampmann, et al; TBNET. 2009. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur. Respir. J. 33: 956-973.
30. Srivastava, V., M. Manchanda, S. Gupta, R. Singla, D. Behera, G. Das, and K. Natarajan. 2009. Toll-like receptor 2 and DC-SIGNR1 differentially regulate suppressors of cytokine signaling 1 in dendritic cells during Mycobacterium tuberculosis infection. J. Biol. Chem. 284: 25532-25541.
31. Rothfuchs, A. G., A. Bafica, C. G. Feng, J. G. Egen, D. L. Williams, G. D. Brown, and A. Sher. 2007. Dectin-1 interaction with Mycobacterium tuberculosis leads to enhanced IL-12p40 production by splenic dendritic cells. J. Immunol. 179: 3463-3471.
32. Wieland, C. W., E. A. Koppel, J. den Dunnen, S. Florquin, A. N. McKenzie, Y. van Kooyk, T. van der Poll, and T. B. Geijtenbeek. 2007. Mice lacking SIGNR1 have stronger T helper 1 responses to Mycobacterium tuberculosis. Microbes Infect. 9: 134-141.
33. Noss, E. H., R. K. Pai, T. J. Sellati, J. D. Radolf, J. Belisle, D. T. Golenbock, W. H. Boom, and C. V. Harding. 2001. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J. Immunol. 167: 910-918.
34. Gehring, A. J., R. E. Rojas, D. H. Canaday, D. L. Lakey, C. V. Harding, and W. H. Boom. 2003. The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits γ interferon-regulated HLA-DR and Fc γ R1 on human macrophages through Toll-like receptor 2. Infect. Immun. 71: 4487-4497.
35. Pennini, M. E., R. K. Pai, D. C. Schultz, W. H. Boom, and C. V. Harding. 2006. Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-γ-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling. J. Immunol. 176: 4323-4330.
36. Salam, N., S. Gupta, S. Sharma, S. Pahujani, A. Sinha, R. K. Saxena, and K. Natarajan. 2008. Protective immunity to Mycobacterium tuberculosis infection by chemokine and cytokine conditioned CFP-10 differentiated dendritic cells. PLoS One 3: e2869.
37. Wang, Y., H. M. Curry, B. S. Zwilling, and W. P. Lafuse. 2005. Mycobacteria inhibition of IFN-γ induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells. J. Immunol. 174: 5687-5694. (Pubitemid 40593211)
38. van Kooyk, Y., and T. B. Geijtenbeek. 2003. DC-SIGN: escape mechanism for pathogens. Nat. Rev. Immunol. 3: 697-709.
39. Henderson, R. A., S. C. Watkins, and J. L. Flynn. 1997. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J. Immunol. 159: 635-643. (Pubitemid 127484212)
40. Tsuji, S., M. Matsumoto, O. Takeuchi, S. Akira, I. Azuma, A. Hayashi, K. Toyoshima, and T. Seya. 2000. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guérin: involvement of toll-like receptors. Infect. Immun. 68: 6883-6890.
41. Kincaid, E. Z., and J. D. Ernst. 2003. Mycobacterium tuberculosis exerts gene-selective inhibition of transcriptional responses to IFN-γ without inhibiting STAT1 function. J. Immunol. 171: 2042-2049.
42. Singhal, A., A. Jaiswal, V. K. Arora, and H. K. Prasad. 2007. Modulation of gamma interferon receptor 1 by Mycobacterium tuberculosis: a potential immune response evasive mechanism. Infect. Immun. 75: 2500-2510.
43. Hisert, K. B., M. A. Kirksey, J. E. Gomez, A. O. Sousa, J. S. Cox, W. R. Jacobs, Jr., C. F. Nathan, and J. D. McKinney. 2004. Identification of Mycobacterium tuberculosis counterimmune (cim) mutants in immunodeficient mice by differential screening. Infect. Immun. 72: 5315-5321.
44. Sendide, K., A.-E. Deghmane, D. Pechkovsky, Y. Av-Gay, A. Talal, and Z. Hmama. 2005. Mycobacterium bovis BCG attenuates surface expression of mature class II molecules through IL-10-dependent inhibition of cathepsin S. J. Immunol. 175: 5324-5332. (Pubitemid 41456418)